 | • レポートコード：MRC2Q12-16955 • 出版社/出版日：QYResearch / 2022年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥710,500 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,421,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、大動脈弁移植（AVG）のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 大動脈弁移植（AVG）のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 大動脈弁移植（AVG）の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 大動脈弁移植（AVG）のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの大動脈弁移植（AVG）の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の大動脈弁移植（AVG）の売上および2028年までの予測に焦点を当てています。 大動脈弁移植（AVG）のグローバル主要企業には、Gore、Terumo、B. Braun、Getinge、CryoLife、Edwards Lifesciences、Medtronic、Abbottなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 大動脈弁移植（AVG）市場は、タイプとアプリケーションによって区分されます。世界の大動脈弁移植（AVG）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 21mm、23mm、25mm、27mm、29mm、その他 【アプリケーション別セグメント】 男性用、女性用 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 大動脈弁移植（AVG）製品概要 - タイプ別市場（21mm、23mm、25mm、27mm、29mm、その他） - アプリケーション別市場（男性用、女性用） - 調査の目的 ・エグゼクティブサマリー - 世界の大動脈弁移植（AVG）販売量予測2017-2028 - 世界の大動脈弁移植（AVG）売上予測2017-2028 - 大動脈弁移植（AVG）の地域別販売量 - 大動脈弁移植（AVG）の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別大動脈弁移植（AVG）販売量 - 主要メーカー別大動脈弁移植（AVG）売上 - 主要メーカー別大動脈弁移植（AVG）価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（21mm、23mm、25mm、27mm、29mm、その他） - 大動脈弁移植（AVG）のタイプ別販売量 - 大動脈弁移植（AVG）のタイプ別売上 - 大動脈弁移植（AVG）のタイプ別価格 ・アプリケーション別市場規模（男性用、女性用） - 大動脈弁移植（AVG）のアプリケーション別販売量 - 大動脈弁移植（AVG）のアプリケーション別売上 - 大動脈弁移植（AVG）のアプリケーション別価格 ・北米市場 - 北米の大動脈弁移植（AVG）市場規模（タイプ別、アプリケーション別） - 主要国別の大動脈弁移植（AVG）市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの大動脈弁移植（AVG）市場規模（タイプ別、アプリケーション別） - 主要国別の大動脈弁移植（AVG）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の大動脈弁移植（AVG）市場規模（タイプ別、アプリケーション別） - 主要国別の大動脈弁移植（AVG）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の大動脈弁移植（AVG）市場規模（タイプ別、アプリケーション別） - 主要国別の大動脈弁移植（AVG）市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの大動脈弁移植（AVG）市場規模（タイプ別、アプリケーション別） - 主要国別の大動脈弁移植（AVG）市場規模（トルコ、サウジアラビア） ・企業情報 Gore、Terumo、B. Braun、Getinge、CryoLife、Edwards Lifesciences、Medtronic、Abbott ・産業チェーン及び販売チャネル分析 - 大動脈弁移植（AVG）の産業チェーン分析 - 大動脈弁移植（AVG）の原材料 - 大動脈弁移植（AVG）の生産プロセス - 大動脈弁移植（AVG）の販売及びマーケティング - 大動脈弁移植（AVG）の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 大動脈弁移植（AVG）の産業動向 - 大動脈弁移植（AVG）のマーケットドライバー - 大動脈弁移植（AVG）の課題 - 大動脈弁移植（AVG）の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Aortic Valved Graft (AVG) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Aortic Valved Graft (AVG) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Aortic Valved Graft (AVG) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Aortic Valved Graft (AVG) include Gore, Terumo, B. Braun, Getinge, CryoLife, Edwards Lifesciences, Medtronic and Abbott, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Aortic Valved Graft (AVG) manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Aortic Valved Graft (AVG) market. Further, it explains the major drivers and regional dynamics of the global Aortic Valved Graft (AVG) market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Gore
Terumo
B. Braun
Getinge
CryoLife
Edwards Lifesciences
Medtronic
Abbott
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Aortic Valved Graft (AVG) Segment by Type
21 mm
23 mm
25 mm
27 mm
29 mm
Other
Aortic Valved Graft (AVG) Segment by Application
Men
Women
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Aortic Valved Graft (AVG) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Aortic Valved Graft (AVG), sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Aortic Valved Graft (AVG), also provides the sales of main regions and countries. Highlights of the upcoming market potential for Aortic Valved Graft (AVG), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Aortic Valved Graft (AVG) sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Aortic Valved Graft (AVG) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Aortic Valved Graft (AVG) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Gore, Terumo, B. Braun, Getinge, CryoLife, Edwards Lifesciences, Medtronic and Abbott, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Aortic Valved Graft (AVG) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Aortic Valved Graft (AVG) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aortic Valved Graft (AVG) sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Aortic Valved Graft (AVG) Product Introduction
1.2 Market by Type
1.2.1 Global Aortic Valved Graft (AVG) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 21 mm
1.2.3 23 mm
1.2.4 25 mm
1.2.5 27 mm
1.2.6 29 mm
1.2.7 Other
1.3 Market by Application
1.3.1 Global Aortic Valved Graft (AVG) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Men
1.3.3 Women
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Aortic Valved Graft (AVG) Sales Estimates and Forecasts 2017-2028
2.2 Global Aortic Valved Graft (AVG) Revenue Estimates and Forecasts 2017-2028
2.3 Global Aortic Valved Graft (AVG) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Aortic Valved Graft (AVG) Sales by Region
2.4.1 Global Aortic Valved Graft (AVG) Sales by Region (2017-2022)
2.4.2 Global Sales Aortic Valved Graft (AVG) by Region (2023-2028)
2.5 Global Aortic Valved Graft (AVG) Revenue by Region
2.5.1 Global Aortic Valved Graft (AVG) Revenue by Region (2017-2022)
2.5.2 Global Aortic Valved Graft (AVG) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Aortic Valved Graft (AVG) Sales by Manufacturers
3.1.1 Global Top Aortic Valved Graft (AVG) Manufacturers by Sales (2017-2022)
3.1.2 Global Aortic Valved Graft (AVG) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Aortic Valved Graft (AVG) in 2021
3.2 Global Aortic Valved Graft (AVG) Revenue by Manufacturers
3.2.1 Global Aortic Valved Graft (AVG) Revenue by Manufacturers (2017-2022)
3.2.2 Global Aortic Valved Graft (AVG) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Aortic Valved Graft (AVG) Revenue in 2021
3.3 Global Aortic Valved Graft (AVG) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Aortic Valved Graft (AVG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Aortic Valved Graft (AVG) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Aortic Valved Graft (AVG) Sales by Type
4.1.1 Global Aortic Valved Graft (AVG) Historical Sales by Type (2017-2022)
4.1.2 Global Aortic Valved Graft (AVG) Forecasted Sales by Type (2023-2028)
4.1.3 Global Aortic Valved Graft (AVG) Sales Market Share by Type (2017-2028)
4.2 Global Aortic Valved Graft (AVG) Revenue by Type
4.2.1 Global Aortic Valved Graft (AVG) Historical Revenue by Type (2017-2022)
4.2.2 Global Aortic Valved Graft (AVG) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Aortic Valved Graft (AVG) Revenue Market Share by Type (2017-2028)
4.3 Global Aortic Valved Graft (AVG) Price by Type
4.3.1 Global Aortic Valved Graft (AVG) Price by Type (2017-2022)
4.3.2 Global Aortic Valved Graft (AVG) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Aortic Valved Graft (AVG) Sales by Application
5.1.1 Global Aortic Valved Graft (AVG) Historical Sales by Application (2017-2022)
5.1.2 Global Aortic Valved Graft (AVG) Forecasted Sales by Application (2023-2028)
5.1.3 Global Aortic Valved Graft (AVG) Sales Market Share by Application (2017-2028)
5.2 Global Aortic Valved Graft (AVG) Revenue by Application
5.2.1 Global Aortic Valved Graft (AVG) Historical Revenue by Application (2017-2022)
5.2.2 Global Aortic Valved Graft (AVG) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Aortic Valved Graft (AVG) Revenue Market Share by Application (2017-2028)
5.3 Global Aortic Valved Graft (AVG) Price by Application
5.3.1 Global Aortic Valved Graft (AVG) Price by Application (2017-2022)
5.3.2 Global Aortic Valved Graft (AVG) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Aortic Valved Graft (AVG) Market Size by Type
6.1.1 North America Aortic Valved Graft (AVG) Sales by Type (2017-2028)
6.1.2 North America Aortic Valved Graft (AVG) Revenue by Type (2017-2028)
6.2 North America Aortic Valved Graft (AVG) Market Size by Application
6.2.1 North America Aortic Valved Graft (AVG) Sales by Application (2017-2028)
6.2.2 North America Aortic Valved Graft (AVG) Revenue by Application (2017-2028)
6.3 North America Aortic Valved Graft (AVG) Market Size by Country
6.3.1 North America Aortic Valved Graft (AVG) Sales by Country (2017-2028)
6.3.2 North America Aortic Valved Graft (AVG) Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Aortic Valved Graft (AVG) Market Size by Type
7.1.1 Europe Aortic Valved Graft (AVG) Sales by Type (2017-2028)
7.1.2 Europe Aortic Valved Graft (AVG) Revenue by Type (2017-2028)
7.2 Europe Aortic Valved Graft (AVG) Market Size by Application
7.2.1 Europe Aortic Valved Graft (AVG) Sales by Application (2017-2028)
7.2.2 Europe Aortic Valved Graft (AVG) Revenue by Application (2017-2028)
7.3 Europe Aortic Valved Graft (AVG) Market Size by Country
7.3.1 Europe Aortic Valved Graft (AVG) Sales by Country (2017-2028)
7.3.2 Europe Aortic Valved Graft (AVG) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Aortic Valved Graft (AVG) Market Size by Type
8.1.1 Asia Pacific Aortic Valved Graft (AVG) Sales by Type (2017-2028)
8.1.2 Asia Pacific Aortic Valved Graft (AVG) Revenue by Type (2017-2028)
8.2 Asia Pacific Aortic Valved Graft (AVG) Market Size by Application
8.2.1 Asia Pacific Aortic Valved Graft (AVG) Sales by Application (2017-2028)
8.2.2 Asia Pacific Aortic Valved Graft (AVG) Revenue by Application (2017-2028)
8.3 Asia Pacific Aortic Valved Graft (AVG) Market Size by Region
8.3.1 Asia Pacific Aortic Valved Graft (AVG) Sales by Region (2017-2028)
8.3.2 Asia Pacific Aortic Valved Graft (AVG) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Aortic Valved Graft (AVG) Market Size by Type
9.1.1 Latin America Aortic Valved Graft (AVG) Sales by Type (2017-2028)
9.1.2 Latin America Aortic Valved Graft (AVG) Revenue by Type (2017-2028)
9.2 Latin America Aortic Valved Graft (AVG) Market Size by Application
9.2.1 Latin America Aortic Valved Graft (AVG) Sales by Application (2017-2028)
9.2.2 Latin America Aortic Valved Graft (AVG) Revenue by Application (2017-2028)
9.3 Latin America Aortic Valved Graft (AVG) Market Size by Country
9.3.1 Latin America Aortic Valved Graft (AVG) Sales by Country (2017-2028)
9.3.2 Latin America Aortic Valved Graft (AVG) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Aortic Valved Graft (AVG) Market Size by Type
10.1.1 Middle East and Africa Aortic Valved Graft (AVG) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Aortic Valved Graft (AVG) Revenue by Type (2017-2028)
10.2 Middle East and Africa Aortic Valved Graft (AVG) Market Size by Application
10.2.1 Middle East and Africa Aortic Valved Graft (AVG) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Aortic Valved Graft (AVG) Revenue by Application (2017-2028)
10.3 Middle East and Africa Aortic Valved Graft (AVG) Market Size by Country
10.3.1 Middle East and Africa Aortic Valved Graft (AVG) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Aortic Valved Graft (AVG) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Gore
11.1.1 Gore Corporation Information
11.1.2 Gore Overview
11.1.3 Gore Aortic Valved Graft (AVG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Gore Aortic Valved Graft (AVG) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Gore Recent Developments
11.2 Terumo
11.2.1 Terumo Corporation Information
11.2.2 Terumo Overview
11.2.3 Terumo Aortic Valved Graft (AVG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Terumo Aortic Valved Graft (AVG) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Terumo Recent Developments
11.3 B. Braun
11.3.1 B. Braun Corporation Information
11.3.2 B. Braun Overview
11.3.3 B. Braun Aortic Valved Graft (AVG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 B. Braun Aortic Valved Graft (AVG) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 B. Braun Recent Developments
11.4 Getinge
11.4.1 Getinge Corporation Information
11.4.2 Getinge Overview
11.4.3 Getinge Aortic Valved Graft (AVG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Getinge Aortic Valved Graft (AVG) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Getinge Recent Developments
11.5 CryoLife
11.5.1 CryoLife Corporation Information
11.5.2 CryoLife Overview
11.5.3 CryoLife Aortic Valved Graft (AVG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CryoLife Aortic Valved Graft (AVG) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CryoLife Recent Developments
11.6 Edwards Lifesciences
11.6.1 Edwards Lifesciences Corporation Information
11.6.2 Edwards Lifesciences Overview
11.6.3 Edwards Lifesciences Aortic Valved Graft (AVG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Edwards Lifesciences Aortic Valved Graft (AVG) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Edwards Lifesciences Recent Developments
11.7 Medtronic
11.7.1 Medtronic Corporation Information
11.7.2 Medtronic Overview
11.7.3 Medtronic Aortic Valved Graft (AVG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Medtronic Aortic Valved Graft (AVG) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Medtronic Recent Developments
11.8 Abbott
11.8.1 Abbott Corporation Information
11.8.2 Abbott Overview
11.8.3 Abbott Aortic Valved Graft (AVG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Abbott Aortic Valved Graft (AVG) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Abbott Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Aortic Valved Graft (AVG) Industry Chain Analysis
12.2 Aortic Valved Graft (AVG) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Aortic Valved Graft (AVG) Production Mode & Process
12.4 Aortic Valved Graft (AVG) Sales and Marketing
12.4.1 Aortic Valved Graft (AVG) Sales Channels
12.4.2 Aortic Valved Graft (AVG) Distributors
12.5 Aortic Valved Graft (AVG) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Aortic Valved Graft (AVG) Industry Trends
13.2 Aortic Valved Graft (AVG) Market Drivers
13.3 Aortic Valved Graft (AVG) Market Challenges
13.4 Aortic Valved Graft (AVG) Market Restraints
14 Key Findings in The Global Aortic Valved Graft (AVG) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
| 【大動脈弁移植（AVG）について】 大動脈弁移植（AVG）とは、大動脈弁の機能不全や狭窄に伴う心血管系の問題を解決するために使用される外科的治療法の一つです。この手技は、患者の大動脈弁を人工の弁または生体材料で置換することによって、心臓の正常な血液循環を回復し、心血管の健康を改善することを目的としています。 大動脈弁は心臓の左心室と大動脈の間に位置し、心臓から全身に血液を送り出す際、その逆流を防ぐ重要な役割を果たします。この弁に異常が生じると、心不全や不整脈、さらには場合によっては死亡に至ることもあります。そのため、大動脈弁の移植は心臓手術の中でも重要な位置を占めているのです。 AVGにはいくつかの特徴があります。まず、弁置換の方法として、人工弁と生体弁の2種類があります。人工弁は通常、金属やプラスチックなどの合成材料から作られており、耐久性が高く長寿命であることが特徴です。一方で、生体弁は動物の組織を用いており、体内に適合しやすく、抗凝固療法を必要としない場合が多いと言えます。 AVGは、特定の条件や状況に応じて適用されます。たとえ患者が高齢であったり、重大な合併症を抱えている場合でも、AVGは心機能の改善を図る有効な手段となることがあります。特に、弁狭窄や弁閉鎖不全といった病状に対して、AVGは優れた治療成果を示すことが多いです。 また、AVGは一般的に心臓手術の一環として行われます。手術は全身麻酔下で行われ、胸部の開胸または胸腔鏡手術（ミニ開胸）を通じて実施されます。手術後は患者は一定期間の入院を要し、術後の合併症として、感染症や出血、血栓形成などに注意が必要です。 近年は、AVGの技術・手法も進化しており、特に経皮的大動脈弁置換術（TAVR）などの新たなアプローチが注目されています。TAVRは小さな切開からカテーテルを使って大動脈弁を置換する技術で、通常の開心手術に比べて侵襲が少なく、回復が早いという利点があります。このように、AVGに関連する技術の革新は、さらに多くの患者にとっての選択肢を広げることに寄与しています。 次に、大動脈弁移植の種別について詳しく見てみましょう。一つ目は機械弁で、これは金属や特殊プラスチックで構成されており、寿命が非常に長いという特性を持っています。ただし、機械弁は血栓を形成するリスクがあるため、患者は抗凝固薬を生涯にわたって服用する必要があります。二つ目は生体弁で、豚や牛の心臓の一部を用いたものです。これらは体内に適合しやすく、抗凝固薬を必要としないことが多いですが、耐久性では機械弁には及ばない場合があります。 また、AVGの用途は広範囲にわたります。特に、重度の大動脈弁狭窄、弁閉鎖不全、感染性心内膜炎、心筋梗塞後の合併症としての弁機能不全などが挙げられます。これらの状態にある患者は、AVGによって心血管機能を改善し、生活の質を高めることが期待されます。 関連技術としては、術中のモニタリング技術や画像診断技術が挙げられます。たとえば、心エコー検査やCTスキャンを駆使して、手術前の評価や術後の経過観察が行われます。他にも、腹腔鏡手術により侵襲を軽減する技術や、ロボット支援手術が導入されることで、手術の精度や安全性が向上しています。 総じて、大動脈弁移植は高い治療効果を持ちながらも、患者の状態や年齢に応じて選択されるべき手段です。加齢に伴う心臓疾患の増加を考慮すると、この技術の重要性はさらに増していくでしょう。心臓病治療の進展に寄与するAVGの発展は、今後の医学の発展においても重要なテーマであり、研究や技術の革新に期待が寄せられています。 |